喘作为一种系统性疾病:与喘相关的心血管影响
1University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. tattersall@wisc.edu.
Advances in experimental medicine and biology
|July 18, 2023
概括
由于系统性炎症,喘患者面临更高的心血管疾病 (CVD) 风险. 识别患有喘的高风险个体对于针对性预防和治疗心血管疾病至关重要.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 喘和心血管疾病 (CVD) 是主要的公共卫生问题.
- 喘中的系统性炎症有助于心血管疾病的病理生理学.
- 流行病学研究将喘与诸如动脉损伤,动脉样硬化事件,心房动和高血压等不良心血管结果联系起来.
研究的目的:
- 探索喘和心血管疾病风险之间的复杂关系.
- 解决心血管疾病风险在喘表型和内型之间异质性的问题.
- 强调需要精确医学方法来管理喘患者心血管疾病风险.
主要方法:
- 对流行病学研究和病理生理学机制的审查.
- 分析与喘相关的心血管影响.
- 检查喘的临床表型和分子内型.
主要成果:
- 喘与各种心血管疾病的风险增加有关.
- 在所有喘亚型中,心血管疾病的风险并不均.
- 连接喘和心血管疾病的机制是多因素的,并未完全理解.
结论:
- 需要精确的方法来识别患有心血管疾病高风险的喘患者.
- 有针对性的诊断和预防策略对于降低喘中心血管疾病负担至关重要.
- 需要进行进一步的研究,以阐明喘中心血管疾病风险背后的多因素机制.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
449
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
449
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists
310
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
310


